Incidence of arrhythmia in chronic lymphocytic leukemia (CLL) patients treated with ibrutinib: a real-world retrospective analysis from two Italian centers.

被引：0
|
作者：
Murru, Roberta
Innocenti, Idanna
Galitzia, Andrea
Tomasso, Annamaria
Oggianu, Valeria
Laurenti, Luca
La Nasa, Giorgio
机构：
来源：
LEUKEMIA & LYMPHOMA | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1553534
引用
收藏
页码：S162 / S163
页数：2
相关论文
共 50 条
  • [21] Real-world risk of bleeding events in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) treated with BTKi
    Moslehi, Javid J.
    Wahlstrom, Svea K.
    Teschemaker, Anna
    Mackey, Rachel H.
    DeVincenzo, Diana
    Carabuena, Leslie A.
    Thompson, Samantha L.
    Gordon, Brittaney
    Rosenthal, Ning A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Real-World Outcome of Treatment with Single-Agent Ibrutinib in Patients with Chronic Lymphocytic Leukemia: Results from the Italian Study Evidence
    Molica, Stefano
    Scalzulli, Potito Rosario
    Scarfo, Lydia
    Guarini, Attilio
    Murru, Roberta
    Sportoletti, Paolo
    Frigeri, Ferdinando
    Albano, Francesco
    Di Renzo, Nicola
    Sanna, Alessandro
    Innocenti, Idanna
    Massaia, Massimo
    Coscia, Marta
    Pennese, Elsa
    Patti, Caterina
    Reda, Gianluigi
    Tafuri, Agostino
    Regazzoni, Giulia
    Di Candia, Michele
    Mauro, Francesca Romana
    BLOOD, 2022, 140 : 4178 - 4180
  • [23] Real-world experience of ibrutinib therapy in relapsed chronic lymphocytic leukemia: results of a single-center retrospective analysis
    Nuttall, Elisabeth
    Tung, Joanna
    Trounce, Ellie
    Johnston, Rosalynd
    Chevassut, Timothy
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 199 - 208
  • [24] Incidence of Autoimmune Cytopenias (AIC) in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (CLL/SLL) Patients (pts) Treated with Ibrutinib
    Rogers, Kerry A.
    Woyach, Jennifer A.
    Andritsos, Leslie A.
    Awan, Farrukh
    Blum, Kristie A.
    Flynn, Joseph M.
    Jaglowski, Samantha
    Lozanski, Gerard
    Maddocks, Kami J.
    Byrd, John C.
    Jones, Jeffrey A.
    BLOOD, 2014, 124 (21)
  • [25] Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
    Muta, Tsuyoshi
    Masamoto, Yosuke
    Yamamoto, Go
    Kurahashi, Shingo
    Kameoka, Yoshihiro
    Ota, Shuichi
    Matsuki, Eri
    Ozeki, Kazutaka
    Toyama, Takanori
    Takahashi, Naoki
    Kumode, Takahiro
    Aotsuka, Nobuyuki
    Yoshimura, Takuro
    Tamura, Hideto
    Omi, Ai
    Shibayama, Kazuhiro
    Watanabe, Aki
    Isobe, Yasushi
    Kojima, Kensuke
    Takizawa, Jun
    Nagai, Hirokazu
    Suzumiya, Junji
    Aoki, Sadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, : 161 - 173
  • [26] Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Shadman, Mazyar
    Salkar, Monika
    Srivastava, Bhavini
    Karve, Sudeep
    Emond, Bruno
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Agatep, Barnabie
    Jones, Barton
    Franceschini, Erin
    Saifan, Chadi
    Bacchus, Shaffee
    Roeker, Lindsey
    Stephens, Deborah M.
    LEUKEMIA & LYMPHOMA, 2024,
  • [27] Real-world ibrutinib dose reductions, holds and discontinuations in chronic lymphocytic leukemia
    Hou, Jing-Zhou
    Ryan, Kellie
    Du, Senxi
    Fang, Bruno
    Marks, Stanley
    Page, Ray
    Peng, Eileen
    Szymanski, Keith
    Winters, Sharon
    Le, Hannah
    FUTURE ONCOLOGY, 2021, 17 (35) : 4959 - 4969
  • [28] Real-World Outcomes of Second-Line Chronic Lymphocytic Leukemia Treatments: Retrospective Analysis of the Brazilian Registry of CLL
    de Lacerda, Marcelo Pitombeira
    Marques, Fernanda de Morais
    Pfister, Verena
    Parra, Flavia de Carvalho
    de Molla, Vinicius Campos
    Buccheri, Valeria
    Gaiolla, Rafael Dezen
    Fogliatto, Laura Maria
    Santucci, Rodrigo
    Bellesso, Marcelo
    Fortier, Sergio Costa
    Silveira, Talita M. B.
    Ribeiro, Glaciano
    Hamerschlak, Nelson
    Yamamoto, Mihoko
    Goncalves, Matheus Vescovi
    Chiattone, Carlos S.
    Arrais-Rodrigues, Celso
    BLOOD, 2022, 140 : 7041 - 7042
  • [29] Impact of Ibrutinib in Quality of Life (QoL) in Patients with Chronic Lymphocytic Leukemia(CLL): Real World Experience in Argentina
    Mela Osorio, Maria Jose
    Pavlovsky, Astrid
    Pavlovsky, Carolina
    Fernandez, Isolda I.
    Clavijo, Manuela
    Miroli, Augusto
    Sackmann, Federico
    Remaggi, Guillermina
    Ferrari, Luciana C.
    Juni, Mariana
    Sighel, Carolina
    Riddick, Maximiliano
    Arturo Pavlovsky, Miguel
    BLOOD, 2022, 140 : 12403 - 12404
  • [30] Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naive Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis
    Ronconi, Giulia
    Dondi, Letizia
    Calabria, Silvia
    Piccinni, Carlo
    Pedrini, Antonella
    Esposito, Immacolata
    Martini, Nello
    CLINICAL DRUG INVESTIGATION, 2021, 41 (07) : 595 - 604
12345